Drug Utilization Review Board – Part One

Regulatory
November 18, 2021
  • Twitter
  • Facebook
  • Google+
  • Linkedin
Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. Membership: Physicians and pharmacists Robert L. Hogue, M.D., F.A.A.F.M. (Brownwood) (Chair) Alejandro D. Kudisch, M.D., D.F. A.P.A. (McAllen) (Vice-chair) Scott Blaszczyk, Pharm.D., BCGP (Dallas) Deborah E. Briggs, M.D. (Austin) Marlo Brawner, M.D. (Livingston) - term ending Aug. 31, 2021 Deeatra S. Craddock, Pharm. D, BCACP (Carrollton) Jennifer Fix, Pharm. D (Burleson) Heather Holmes, M.D. (Amarillo) Joshua R. Johns, Pharm. D. (Richardson) Sarah E. Kubes, Pharm. D. (San Antonio) Jill N. Lester, Pharm. D. (Dallas) - term ending Aug. 31, 2021 Thanhhao T. Ngo, Pharm. D. (Austin) - term ending Aug. 31, 2021 Richard Noel, M.D. (Spring) Kim Pham, D.O. (Dallas)

Subscribe to gain full access to all of our must-have reports and videos

OR

Log in